nodes	percent_of_prediction	percent_of_DWPC	metapath
Toremifene—ABCB1—peripheral nervous system neoplasm	0.362	1	CbGaD
Toremifene—CYP1A1—Tretinoin—peripheral nervous system neoplasm	0.0881	0.184	CbGbCtD
Toremifene—CYP1A1—Dacarbazine—peripheral nervous system neoplasm	0.0758	0.158	CbGbCtD
Toremifene—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0423	0.0886	CbGbCtD
Toremifene—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.037	0.0774	CbGbCtD
Toremifene—ABCB1—Topotecan—peripheral nervous system neoplasm	0.037	0.0774	CbGbCtD
Toremifene—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0338	0.0708	CbGbCtD
Toremifene—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0257	0.0537	CbGbCtD
Toremifene—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0222	0.0464	CbGbCtD
Toremifene—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0206	0.0431	CbGbCtD
Toremifene—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0166	0.0346	CbGbCtD
Toremifene—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0158	0.0331	CbGbCtD
Toremifene—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0147	0.0308	CbGbCtD
Toremifene—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0145	0.0303	CbGbCtD
Toremifene—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00988	0.0207	CbGbCtD
Toremifene—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00947	0.0198	CbGbCtD
Toremifene—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00867	0.0181	CbGbCtD
Toremifene—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00592	0.0124	CbGbCtD
Toremifene—Constipation—Tretinoin—peripheral nervous system neoplasm	0.000255	0.00159	CcSEcCtD
Toremifene—Pain—Isotretinoin—peripheral nervous system neoplasm	0.000255	0.00159	CcSEcCtD
Toremifene—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.000255	0.00159	CcSEcCtD
Toremifene—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.000254	0.00158	CcSEcCtD
Toremifene—Fatigue—Melphalan—peripheral nervous system neoplasm	0.000254	0.00158	CcSEcCtD
Toremifene—Eye disorder—Cisplatin—peripheral nervous system neoplasm	0.000253	0.00158	CcSEcCtD
Toremifene—Pain—Melphalan—peripheral nervous system neoplasm	0.000252	0.00157	CcSEcCtD
Toremifene—Mediastinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000244	0.00152	CcSEcCtD
Toremifene—Oedema—Dactinomycin—peripheral nervous system neoplasm	0.000244	0.00152	CcSEcCtD
Toremifene—Arrhythmia—Cisplatin—peripheral nervous system neoplasm	0.000242	0.00151	CcSEcCtD
Toremifene—Abnormal vision—Epirubicin—peripheral nervous system neoplasm	0.000242	0.00151	CcSEcCtD
Toremifene—Vertigo—Vincristine—peripheral nervous system neoplasm	0.00024	0.0015	CcSEcCtD
Toremifene—Alopecia—Cisplatin—peripheral nervous system neoplasm	0.000239	0.00149	CcSEcCtD
Toremifene—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.000239	0.00149	CcSEcCtD
Toremifene—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.000239	0.00149	CcSEcCtD
Toremifene—Dry eye—Doxorubicin—peripheral nervous system neoplasm	0.000237	0.00148	CcSEcCtD
Toremifene—Malnutrition—Cisplatin—peripheral nervous system neoplasm	0.000236	0.00147	CcSEcCtD
Toremifene—Chest pain—Alitretinoin—peripheral nervous system neoplasm	0.000236	0.00147	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.000234	0.00146	CcSEcCtD
Toremifene—Thrombophlebitis—Epirubicin—peripheral nervous system neoplasm	0.000232	0.00145	CcSEcCtD
Toremifene—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.000232	0.00145	CcSEcCtD
Toremifene—Eye disorder—Etoposide—peripheral nervous system neoplasm	0.000232	0.00145	CcSEcCtD
Toremifene—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.000226	0.00141	CcSEcCtD
Toremifene—Angiopathy—Etoposide—peripheral nervous system neoplasm	0.000225	0.0014	CcSEcCtD
Toremifene—Mediastinal disorder—Etoposide—peripheral nervous system neoplasm	0.000224	0.0014	CcSEcCtD
Toremifene—Abnormal vision—Doxorubicin—peripheral nervous system neoplasm	0.000224	0.00139	CcSEcCtD
Toremifene—Chills—Etoposide—peripheral nervous system neoplasm	0.000223	0.00139	CcSEcCtD
Toremifene—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.000222	0.00139	CcSEcCtD
Toremifene—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.000222	0.00138	CcSEcCtD
Toremifene—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.000221	0.00138	CcSEcCtD
Toremifene—Tremor—Cisplatin—peripheral nervous system neoplasm	0.000221	0.00138	CcSEcCtD
Toremifene—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.000219	0.00137	CcSEcCtD
Toremifene—Alopecia—Etoposide—peripheral nervous system neoplasm	0.000219	0.00137	CcSEcCtD
Toremifene—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.000218	0.00136	CcSEcCtD
Toremifene—Oedema—Vincristine—peripheral nervous system neoplasm	0.000218	0.00136	CcSEcCtD
Toremifene—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000216	0.00135	CcSEcCtD
Toremifene—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.000215	0.00134	CcSEcCtD
Toremifene—Hot flush—Epirubicin—peripheral nervous system neoplasm	0.000215	0.00134	CcSEcCtD
Toremifene—Thrombophlebitis—Doxorubicin—peripheral nervous system neoplasm	0.000215	0.00134	CcSEcCtD
Toremifene—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000214	0.00133	CcSEcCtD
Toremifene—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000214	0.00133	CcSEcCtD
Toremifene—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000213	0.00133	CcSEcCtD
Toremifene—Menopausal symptoms—Epirubicin—peripheral nervous system neoplasm	0.000213	0.00133	CcSEcCtD
Toremifene—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.000213	0.00133	CcSEcCtD
Toremifene—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000213	0.00133	CcSEcCtD
Toremifene—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000212	0.00132	CcSEcCtD
Toremifene—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.000211	0.00132	CcSEcCtD
Toremifene—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000211	0.00132	CcSEcCtD
Toremifene—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000211	0.00132	CcSEcCtD
Toremifene—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000211	0.00132	CcSEcCtD
Toremifene—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.00021	0.00131	CcSEcCtD
Toremifene—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.00021	0.00131	CcSEcCtD
Toremifene—Back pain—Etoposide—peripheral nervous system neoplasm	0.000209	0.0013	CcSEcCtD
Toremifene—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000208	0.0013	CcSEcCtD
Toremifene—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000208	0.0013	CcSEcCtD
Toremifene—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000207	0.00129	CcSEcCtD
Toremifene—Cardiac failure—Epirubicin—peripheral nervous system neoplasm	0.000206	0.00129	CcSEcCtD
Toremifene—Lethargy—Epirubicin—peripheral nervous system neoplasm	0.000205	0.00128	CcSEcCtD
Toremifene—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000204	0.00127	CcSEcCtD
Toremifene—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000201	0.00126	CcSEcCtD
Toremifene—Diplopia—Epirubicin—peripheral nervous system neoplasm	0.000201	0.00125	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000199	0.00124	CcSEcCtD
Toremifene—Hot flush—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.00124	CcSEcCtD
Toremifene—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000199	0.00124	CcSEcCtD
Toremifene—Affect lability—Epirubicin—peripheral nervous system neoplasm	0.000198	0.00124	CcSEcCtD
Toremifene—Menopausal symptoms—Doxorubicin—peripheral nervous system neoplasm	0.000197	0.00123	CcSEcCtD
Toremifene—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000197	0.00123	CcSEcCtD
Toremifene—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000197	0.00123	CcSEcCtD
Toremifene—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000197	0.00123	CcSEcCtD
Toremifene—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000196	0.00123	CcSEcCtD
Toremifene—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000195	0.00122	CcSEcCtD
Toremifene—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000195	0.00122	CcSEcCtD
Toremifene—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000194	0.00121	CcSEcCtD
Toremifene—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000193	0.00121	CcSEcCtD
Toremifene—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000193	0.00121	CcSEcCtD
Toremifene—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000193	0.00121	CcSEcCtD
Toremifene—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000192	0.0012	CcSEcCtD
Toremifene—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000191	0.00119	CcSEcCtD
Toremifene—Cardiac failure—Doxorubicin—peripheral nervous system neoplasm	0.000191	0.00119	CcSEcCtD
Toremifene—Mood swings—Epirubicin—peripheral nervous system neoplasm	0.000191	0.00119	CcSEcCtD
Toremifene—Lethargy—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.00118	CcSEcCtD
Toremifene—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00019	0.00118	CcSEcCtD
Toremifene—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00019	0.00118	CcSEcCtD
Toremifene—Rash—Topotecan—peripheral nervous system neoplasm	0.000189	0.00118	CcSEcCtD
Toremifene—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000189	0.00118	CcSEcCtD
Toremifene—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000189	0.00118	CcSEcCtD
Toremifene—Ataxia—Epirubicin—peripheral nervous system neoplasm	0.000189	0.00118	CcSEcCtD
Toremifene—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000189	0.00118	CcSEcCtD
Toremifene—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000188	0.00118	CcSEcCtD
Toremifene—Headache—Topotecan—peripheral nervous system neoplasm	0.000188	0.00117	CcSEcCtD
Toremifene—Rash—Tretinoin—peripheral nervous system neoplasm	0.000188	0.00117	CcSEcCtD
Toremifene—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000188	0.00117	CcSEcCtD
Toremifene—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000188	0.00117	CcSEcCtD
Toremifene—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000188	0.00117	CcSEcCtD
Toremifene—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000188	0.00117	CcSEcCtD
Toremifene—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000188	0.00117	CcSEcCtD
Toremifene—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000187	0.00117	CcSEcCtD
Toremifene—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000187	0.00117	CcSEcCtD
Toremifene—Headache—Tretinoin—peripheral nervous system neoplasm	0.000187	0.00117	CcSEcCtD
Toremifene—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000187	0.00117	CcSEcCtD
Toremifene—Constipation—Vincristine—peripheral nervous system neoplasm	0.000186	0.00116	CcSEcCtD
Toremifene—Pain—Vincristine—peripheral nervous system neoplasm	0.000186	0.00116	CcSEcCtD
Toremifene—Diplopia—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.00116	CcSEcCtD
Toremifene—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000186	0.00116	CcSEcCtD
Toremifene—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.000186	0.00116	CcSEcCtD
Toremifene—Rash—Melphalan—peripheral nervous system neoplasm	0.000186	0.00116	CcSEcCtD
Toremifene—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000185	0.00116	CcSEcCtD
Toremifene—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000184	0.00115	CcSEcCtD
Toremifene—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000183	0.00114	CcSEcCtD
Toremifene—Affect lability—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.00114	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000183	0.00114	CcSEcCtD
Toremifene—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.000182	0.00113	CcSEcCtD
Toremifene—Nausea—Topotecan—peripheral nervous system neoplasm	0.000178	0.00111	CcSEcCtD
Toremifene—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000177	0.0011	CcSEcCtD
Toremifene—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000177	0.0011	CcSEcCtD
Toremifene—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.000176	0.0011	CcSEcCtD
Toremifene—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.00109	CcSEcCtD
Toremifene—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000175	0.00109	CcSEcCtD
Toremifene—Nausea—Melphalan—peripheral nervous system neoplasm	0.000175	0.00109	CcSEcCtD
Toremifene—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000173	0.00108	CcSEcCtD
Toremifene—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.00107	CcSEcCtD
Toremifene—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000172	0.00107	CcSEcCtD
Toremifene—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000171	0.00107	CcSEcCtD
Toremifene—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.00017	0.00106	CcSEcCtD
Toremifene—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000169	0.00106	CcSEcCtD
Toremifene—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.00105	CcSEcCtD
Toremifene—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000168	0.00105	CcSEcCtD
Toremifene—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000167	0.00104	CcSEcCtD
Toremifene—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000166	0.00104	CcSEcCtD
Toremifene—Pain—Cisplatin—peripheral nervous system neoplasm	0.000165	0.00103	CcSEcCtD
Toremifene—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000162	0.00101	CcSEcCtD
Toremifene—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00016	0.000997	CcSEcCtD
Toremifene—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000987	CcSEcCtD
Toremifene—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000157	0.000981	CcSEcCtD
Toremifene—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.000977	CcSEcCtD
Toremifene—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000156	0.000974	CcSEcCtD
Toremifene—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000155	0.000967	CcSEcCtD
Toremifene—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000154	0.000958	CcSEcCtD
Toremifene—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000153	0.000956	CcSEcCtD
Toremifene—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000152	0.00095	CcSEcCtD
Toremifene—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000152	0.000949	CcSEcCtD
Toremifene—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000948	CcSEcCtD
Toremifene—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000151	0.000943	CcSEcCtD
Toremifene—Pain—Etoposide—peripheral nervous system neoplasm	0.000151	0.000941	CcSEcCtD
Toremifene—Constipation—Etoposide—peripheral nervous system neoplasm	0.000151	0.000941	CcSEcCtD
Toremifene—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000149	0.000932	CcSEcCtD
Toremifene—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000927	CcSEcCtD
Toremifene—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000147	0.000915	CcSEcCtD
Toremifene—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000913	CcSEcCtD
Toremifene—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000145	0.000903	CcSEcCtD
Toremifene—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000144	0.000898	CcSEcCtD
Toremifene—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000144	0.000896	CcSEcCtD
Toremifene—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000142	0.000889	CcSEcCtD
Toremifene—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000142	0.000888	CcSEcCtD
Toremifene—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000142	0.000883	CcSEcCtD
Toremifene—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000877	CcSEcCtD
Toremifene—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.000872	CcSEcCtD
Toremifene—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000138	0.000864	CcSEcCtD
Toremifene—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000138	0.000862	CcSEcCtD
Toremifene—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000858	CcSEcCtD
Toremifene—Rash—Vincristine—peripheral nervous system neoplasm	0.000137	0.000856	CcSEcCtD
Toremifene—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000137	0.000856	CcSEcCtD
Toremifene—Headache—Vincristine—peripheral nervous system neoplasm	0.000136	0.000851	CcSEcCtD
Toremifene—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000846	CcSEcCtD
Toremifene—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000134	0.000837	CcSEcCtD
Toremifene—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000837	CcSEcCtD
Toremifene—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.00013	0.000811	CcSEcCtD
Toremifene—Nausea—Vincristine—peripheral nervous system neoplasm	0.000129	0.000807	CcSEcCtD
Toremifene—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000127	0.000789	CcSEcCtD
Toremifene—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000788	CcSEcCtD
Toremifene—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000782	CcSEcCtD
Toremifene—Chills—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000779	CcSEcCtD
Toremifene—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000125	0.000778	CcSEcCtD
Toremifene—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000775	CcSEcCtD
Toremifene—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000774	CcSEcCtD
Toremifene—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000767	CcSEcCtD
Toremifene—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000122	0.000764	CcSEcCtD
Toremifene—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000122	0.00076	CcSEcCtD
Toremifene—Rash—Cisplatin—peripheral nervous system neoplasm	0.000121	0.000757	CcSEcCtD
Toremifene—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000121	0.000756	CcSEcCtD
Toremifene—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000756	CcSEcCtD
Toremifene—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000751	CcSEcCtD
Toremifene—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000731	CcSEcCtD
Toremifene—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000729	CcSEcCtD
Toremifene—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000117	0.000728	CcSEcCtD
Toremifene—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000724	CcSEcCtD
Toremifene—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000721	CcSEcCtD
Toremifene—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000718	CcSEcCtD
Toremifene—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000114	0.000713	CcSEcCtD
Toremifene—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000712	CcSEcCtD
Toremifene—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.00071	CcSEcCtD
Toremifene—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000704	CcSEcCtD
Toremifene—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000112	0.0007	CcSEcCtD
Toremifene—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000699	CcSEcCtD
Toremifene—Rash—Etoposide—peripheral nervous system neoplasm	0.000111	0.000694	CcSEcCtD
Toremifene—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000111	0.000693	CcSEcCtD
Toremifene—Headache—Etoposide—peripheral nervous system neoplasm	0.00011	0.000689	CcSEcCtD
Toremifene—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000679	CcSEcCtD
Toremifene—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000676	CcSEcCtD
Toremifene—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000676	CcSEcCtD
Toremifene—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000659	CcSEcCtD
Toremifene—Nausea—Etoposide—peripheral nervous system neoplasm	0.000105	0.000653	CcSEcCtD
Toremifene—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000643	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000639	CcSEcCtD
Toremifene—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000628	CcSEcCtD
Toremifene—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.0001	0.000626	CcSEcCtD
Toremifene—Oedema—Epirubicin—peripheral nervous system neoplasm	9.88e-05	0.000617	CcSEcCtD
Toremifene—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	9.69e-05	0.000605	CcSEcCtD
Toremifene—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	9.68e-05	0.000604	CcSEcCtD
Toremifene—Skin disorder—Epirubicin—peripheral nervous system neoplasm	9.6e-05	0.000599	CcSEcCtD
Toremifene—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	9.56e-05	0.000596	CcSEcCtD
Toremifene—Chest pain—Doxorubicin—peripheral nervous system neoplasm	9.54e-05	0.000595	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	9.48e-05	0.000591	CcSEcCtD
Toremifene—Anorexia—Epirubicin—peripheral nervous system neoplasm	9.42e-05	0.000588	CcSEcCtD
Toremifene—Oedema—Doxorubicin—peripheral nervous system neoplasm	9.15e-05	0.000571	CcSEcCtD
Toremifene—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	8.97e-05	0.00056	CcSEcCtD
Toremifene—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	8.95e-05	0.000559	CcSEcCtD
Toremifene—Insomnia—Epirubicin—peripheral nervous system neoplasm	8.94e-05	0.000558	CcSEcCtD
Toremifene—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	8.88e-05	0.000554	CcSEcCtD
Toremifene—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	8.84e-05	0.000552	CcSEcCtD
Toremifene—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	8.81e-05	0.00055	CcSEcCtD
Toremifene—Anorexia—Doxorubicin—peripheral nervous system neoplasm	8.72e-05	0.000544	CcSEcCtD
Toremifene—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	8.59e-05	0.000536	CcSEcCtD
Toremifene—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	8.53e-05	0.000532	CcSEcCtD
Toremifene—Fatigue—Epirubicin—peripheral nervous system neoplasm	8.52e-05	0.000532	CcSEcCtD
Toremifene—Pain—Epirubicin—peripheral nervous system neoplasm	8.45e-05	0.000527	CcSEcCtD
Toremifene—Constipation—Epirubicin—peripheral nervous system neoplasm	8.45e-05	0.000527	CcSEcCtD
Toremifene—Insomnia—Doxorubicin—peripheral nervous system neoplasm	8.27e-05	0.000516	CcSEcCtD
Toremifene—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	8.15e-05	0.000509	CcSEcCtD
Toremifene—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	7.95e-05	0.000496	CcSEcCtD
Toremifene—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	7.9e-05	0.000493	CcSEcCtD
Toremifene—Fatigue—Doxorubicin—peripheral nervous system neoplasm	7.89e-05	0.000492	CcSEcCtD
Toremifene—Pain—Doxorubicin—peripheral nervous system neoplasm	7.82e-05	0.000488	CcSEcCtD
Toremifene—Constipation—Doxorubicin—peripheral nervous system neoplasm	7.82e-05	0.000488	CcSEcCtD
Toremifene—Asthenia—Epirubicin—peripheral nervous system neoplasm	7.09e-05	0.000442	CcSEcCtD
Toremifene—Pruritus—Epirubicin—peripheral nervous system neoplasm	6.99e-05	0.000436	CcSEcCtD
Toremifene—Asthenia—Doxorubicin—peripheral nervous system neoplasm	6.56e-05	0.000409	CcSEcCtD
Toremifene—Dizziness—Epirubicin—peripheral nervous system neoplasm	6.54e-05	0.000408	CcSEcCtD
Toremifene—Pruritus—Doxorubicin—peripheral nervous system neoplasm	6.47e-05	0.000404	CcSEcCtD
Toremifene—Vomiting—Epirubicin—peripheral nervous system neoplasm	6.28e-05	0.000392	CcSEcCtD
Toremifene—Rash—Epirubicin—peripheral nervous system neoplasm	6.23e-05	0.000389	CcSEcCtD
Toremifene—Dermatitis—Epirubicin—peripheral nervous system neoplasm	6.23e-05	0.000388	CcSEcCtD
Toremifene—Headache—Epirubicin—peripheral nervous system neoplasm	6.19e-05	0.000386	CcSEcCtD
Toremifene—Dizziness—Doxorubicin—peripheral nervous system neoplasm	6.05e-05	0.000377	CcSEcCtD
Toremifene—Nausea—Epirubicin—peripheral nervous system neoplasm	5.87e-05	0.000366	CcSEcCtD
Toremifene—Vomiting—Doxorubicin—peripheral nervous system neoplasm	5.82e-05	0.000363	CcSEcCtD
Toremifene—Rash—Doxorubicin—peripheral nervous system neoplasm	5.77e-05	0.00036	CcSEcCtD
Toremifene—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	5.76e-05	0.000359	CcSEcCtD
Toremifene—Headache—Doxorubicin—peripheral nervous system neoplasm	5.73e-05	0.000357	CcSEcCtD
Toremifene—Nausea—Doxorubicin—peripheral nervous system neoplasm	5.43e-05	0.000339	CcSEcCtD
